Coinbase Global Inc, the largest U.S. cryptocurrency exchange, has received approval from the U.S. Securities and Exchange Commission (SEC) to list its shares on the Nasdaq, paving the way for …
approval
-
- Science
The Johnson & Johnson Shot Nears Approval, Experts Study Transmission, and More Coronavirus News
Johnson & Johnson’s shot nears approval, experts look at the full scope of vaccine protection, and international Covax shipments begin. Here’s what you should know: Want to receive this weekly …
-
Written By Huizhong Wu China has given broader approval for the domestic-made Sinovac coronavirus vaccine, expanding those who can receive it beyond the high-risk and priority groups already allowed under …
- News
Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines
As part of the globalization of the India-developed COVID-19 vaccine, India’s Bharat Biotech has applied for “Emergency use authorization” (EUA) in the Philippines. EUA was filed earlier this month in …
- Science
‘Fundamentally Broken’ – Elon Musk Spars With FAA Over SpaceX Starship Launch Approval Delay
Musk, pictured at the Satellite 2020 Conference in Washington, DC on March 9, 2020. Anadolu Agency via Getty Images Elon Musk has accused the Federal Aviation Administration (FAA) of having …
-
AstraZeneca Plc will file for Japanese approval of its COVID-19 vaccine as early as mid-February, the Yomiuri newspaper reported, making it the second vaccine maker to seek approval in Japan. …
-
Jayasumana said the National Medicines Regulatory Authority (NMRA) had granted the approval for the emergency use of the British vaccine while several other vaccines were also in the pipeline at …
- Business
Russia’s Sputnik vaccine gets its first approval in the EU, greenlight from UAE amid ongoing trials
A medical worker fills a syringe with the Gam-COVID-Vac vaccine (under the brand name of Sputnik V) at in Butovo, south Moscow. Sergei Savostyanov | TASS | Getty Images DUBAI, …
-
India’s Bharat Biotech submitted on Thursday an application for the emergency use of its COVID-19 vaccines in the Philippines, Food and Drug Administration chief Rolando Enrique Domingo said. If allowed …
-
Over 7.86 lakh people in India have been administered the COVID-19 vaccine, according to the health ministry. There have been four deaths among those vaccinated — three due to cardiac …
-
District Collector G. Veerapandian in a release on Saturday said that the DGCA approval was granted through a certificate on Friday The Orvakal Airport on the outskirts of Kurnool city …
-
While the 3,000 sites across India readies to vaccinate 300 million high-risk individuals beginning with healthcare workers from January 16, scientists and doctors are divided over restricted use approval granted …
-
Home » Website » International » EU: Oxford University’s Covid-19 Vaccine May Receive Emergency Approval By January 29 Associated Press (AP) 2021-01-12T16:41:51+05:30 EU: Oxford University’s Covid-19 Vaccine May Receive Emergency …
-
The emergency use approval has been based on safety and efficacy data from limited follow-up Pfizer’s mRNA vaccine has been approved for emergency use by the UK, Bahrain, Canada, Mexico …
- News
Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip – Health News , Firstpost
Union health secretary Rajesh Bhushn also said that the Centre has not banned the export of any vaccines. The country’s drugs regulator had on 3 January approved Oxford-Astrazeneca’s COVID-19 vaccine, …
-
Amid questions raised by experts and Opposition over the restricted use approval given to Covaxin despite no efficacy data from Phase III trials, Bharat Biotech MD Krishna Ella Monday said …
- News
Coronavirus News Live Updates: Bharat Biotech presser soon amid concerns over ‘hasty’ Covaxin approval – India News , Firstpost
Coronavirus News Live Updates: Some Congress leaders had on Sunday raised serious concern over the grant of approval to Bharat Biotech’s COVID-19 vaccine for restricted use, saying it is ‘premature’ …
- News
COVID-19 vaccine: DCGI grants approval to Covishield, Covaxin; Modi terms it ‘decisive turning point’ – Health News , Firstpost
The DCGI’s approval was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) The DCGI chief addressing …
- News
Covaxin use in clinical trial mode, clarifies health minister after DCGI approval; India’s COVID-19 cases rise to 1.03 cr – Health News , Firstpost
Drug firm Zydus Cadila also received the go-ahead to conduct phase-3 trails for its vaccine candidate ZyCoV-D — the country’s first DNA vaccine candidate against the novel coronavirus infection. As …
-
The World Health Organisation on Sunday welcomed India’s decision of giving emergency use authorisation to Covid-19 vaccines, saying it will help “intensify” and “strengthen” its fight against the ongoing pandemic. …
- News
Bharat Biotech says DCGI approval for COVAXIN is ‘giant leap’ for India’s scientific capability – India News , Firstpost
The company’s managing director, Krishna Ella, claimed that COVAXIN has generated ‘excellent’ data regarding its safety, and robust immune responses to multiple viral proteins COVAXIN vaccine by Bharath Biotech. New …
-
Prime Minister Narendra Modi on Sunday lauded scientists of the country after the Drug Controller General of India (DCGI) gave approval to Serum Institute of India’s ‘Covishield’ vaccine and Bharat …
- News
‘Watershed moment in India’s battle against COVID’: Politicos react over emergency use approval
Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in …
-
After the Drug Controller General of India (DCGI) on Sunday approved the emergency use of both Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for immunisation against Covid-19 in India, Prime Minister …
-
India’s drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZeneca/Oxford shot. COVAXIN has been …
-
The Indian government has granted an in-principle approval for two vaccines against Coronavirus, setting the stage for the roll out of the first phase of mass vaccination in the country. …